The double-edge sword of CRISPR application for in vivo studies

by Impact Journals LLCWorkflow illustration. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28459A new editorial paper titled "The double-edge sword of CRISPR application for in vi

Updated on: January 02,2024 8

The double-edge sword of CRISPR application for in vivo studies

by Impact Journals LLCWorkflow illustration. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28459A new editorial paper titled "The double-edge sword of CRISPR application for in vi

Updated on:January 02,2024 8

New species of bacteria discovered in unusual human infection

JANUARY 18, 2024byKing's College LondonHalf body FDG PET aorto – bi – iliac graft with uptake in the left periureteric region. Credit:Clinical Infection in Practice(2023). DOI: 1

Updated on: March 30,2024 6

New species of bacteria discovered in unusual human infection

JANUARY 18, 2024byKing's College LondonHalf body FDG PET aorto – bi – iliac graft with uptake in the left periureteric region. Credit:Clinical Infection in Practice(2023). DOI: 1

Updated on:March 30,2024 6

FDA approves oral Duvyzat for Duchenne muscular dystrophy

by Lori SolomonThe U.S. Food and Drug Administration has approved Duvyzat (givinostat) as an oral medication for the treatment of Duchenne muscular dystrophy (DMD) in patients six years of age and old

Updated on: March 28,2024 0

FDA approves oral Duvyzat for Duchenne muscular dystrophy

by Lori SolomonThe U.S. Food and Drug Administration has approved Duvyzat (givinostat) as an oral medication for the treatment of Duchenne muscular dystrophy (DMD) in patients six years of age and old

Updated on:March 28,2024 0

Experimental pain med could give patients new option to opioids

by Ernie MundellThe first new kind of pain medication in over two decades could be on the horizon for patients, with promising results announced Tuesday from a company trial.For now, the drug from Ver

Updated on: April 24,2024 15

Experimental pain med could give patients new option to opioids

by Ernie MundellThe first new kind of pain medication in over two decades could be on the horizon for patients, with promising results announced Tuesday from a company trial.For now, the drug from Ver

Updated on:April 24,2024 15

Can a drug like Ozempic help treat addictions to alcohol, opioids or other substances?

by Shalini Arunogiri, Leigh Walker and Roberta Anversa,The ConversationCredit: Markus Winkler from PexelsSemaglutide (sold as Ozempic, Wegovy and Rybelsus) was initially developed to treat diabe

Updated on: April 28,2024 0

Can a drug like Ozempic help treat addictions to alcohol, opioids or other substances?

by Shalini Arunogiri, Leigh Walker and Roberta Anversa,The ConversationCredit: Markus Winkler from PexelsSemaglutide (sold as Ozempic, Wegovy and Rybelsus) was initially developed to treat diabe

Updated on:April 28,2024 0

New study sheds light on how our brains perceive—or fail to perceive—what we see

byAllen Institute for Brain ScienceCredit: Magoi from PexelsA newstudyinNature Neuroscienceon 'visual masking' sheds light on how we 'unsee' things and po

Updated on: January 10,2024 20

New study sheds light on how our brains perceive—or fail to perceive—what we see

byAllen Institute for Brain ScienceCredit: Magoi from PexelsA newstudyinNature Neuroscienceon 'visual masking' sheds light on how we 'unsee' things and po

Updated on:January 10,2024 20

AI2BMD on Nature, advancing protein dynamics with quantum-level precision

Updated on: November 12,2024 0

AI2BMD on Nature, advancing protein dynamics with quantum-level precision

Updated on:November 12,2024 0

Exploring ferumoxytol: A new frontier in MRI contrast agents

by Science China PressDuring the blood pool phase, it significantly shortens the T1and T2relaxation times of the blood, thus achieving bright blood effects in T1-weighted imaging and

Updated on: March 30,2024 0

Exploring ferumoxytol: A new frontier in MRI contrast agents

by Science China PressDuring the blood pool phase, it significantly shortens the T1and T2relaxation times of the blood, thus achieving bright blood effects in T1-weighted imaging and

Updated on:March 30,2024 0

Novel compound AC102 restores hearing in preclinical models of sudden hearing loss

by AudioCure Pharma GmbHThe effect of AC102 on OHC survival after noise exposure in vivo. (A) Schematic of OHCs and IHCs within the cochlea. (B) Quantification of OHCs 14 d after noise exposure reveal

Updated on: April 06,2024 0

Novel compound AC102 restores hearing in preclinical models of sudden hearing loss

by AudioCure Pharma GmbHThe effect of AC102 on OHC survival after noise exposure in vivo. (A) Schematic of OHCs and IHCs within the cochlea. (B) Quantification of OHCs 14 d after noise exposure reveal

Updated on:April 06,2024 0

Simnotrelvir shortens time to resolution of symptoms in COVID-19

by Elana GotkineFor adults with mild-to-moderate COVID-19, early administration of simnotrelvir plus ritonavir shortens the time to sustained resolution of symptoms, according to a study published in

Updated on: March 21,2024 19

Simnotrelvir shortens time to resolution of symptoms in COVID-19

by Elana GotkineFor adults with mild-to-moderate COVID-19, early administration of simnotrelvir plus ritonavir shortens the time to sustained resolution of symptoms, according to a study published in

Updated on:March 21,2024 19

New research finds microplastics in all human placenta samples tested

FEBRUARY 20, 2024by Michael Haederle,University of New MexicoCredit: Pixabay/CC0 Public DomainA flurry of recent studies has found that microplastics are present in virtually everything we consu

Updated on: March 28,2024 0

New research finds microplastics in all human placenta samples tested

FEBRUARY 20, 2024by Michael Haederle,University of New MexicoCredit: Pixabay/CC0 Public DomainA flurry of recent studies has found that microplastics are present in virtually everything we consu

Updated on:March 28,2024 0

Poor trial results may prompt maker to pull ALS drug from market

by Robin FosterFollowing disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market.In astatementissued Friday, Amylyx Pharmaceuticals said t

Updated on: March 20,2024 15

Poor trial results may prompt maker to pull ALS drug from market

by Robin FosterFollowing disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market.In astatementissued Friday, Amylyx Pharmaceuticals said t

Updated on:March 20,2024 15